Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia

Abstract Objective To assess the cost-effectiveness of carbetocin versus oxytocin for prevention of postpartum hemorrhage (PPH) due to uterine atony after vaginal delivery/ cesarean section in women with risk factors for bleeding. Methods A decision treewas developed for vaginal delivery andanot...

Full description

Bibliographic Details
Main Authors: Yaneth Gil-Rojas, Pieralessandro Lasalvia, Fabián Hernández, Camilo Castañeda-Cardona, Diego Rosselli
Format: Article
Language:English
Published: Federação Brasileira das Sociedades de Ginecologia e Obstetrícia 2018-05-01
Series:Revista Brasileira de Ginecologia e Obstetrícia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032018000500242&tlng=en
_version_ 1819284473524518912
author Yaneth Gil-Rojas
Pieralessandro Lasalvia
Fabián Hernández
Camilo Castañeda-Cardona
Diego Rosselli
author_facet Yaneth Gil-Rojas
Pieralessandro Lasalvia
Fabián Hernández
Camilo Castañeda-Cardona
Diego Rosselli
author_sort Yaneth Gil-Rojas
collection DOAJ
description Abstract Objective To assess the cost-effectiveness of carbetocin versus oxytocin for prevention of postpartum hemorrhage (PPH) due to uterine atony after vaginal delivery/ cesarean section in women with risk factors for bleeding. Methods A decision treewas developed for vaginal delivery andanother one for cesarean, in which a sequential analysis of the results was obtained with the use of carbetocin and oxytocin for prevention of PPH and related consequences. A third-party payer perspective was used; only directmedical costs were considered. Incremental costs and effectiveness in terms of quality-adjusted life years (QALYs) were evaluated for a one-year timehorizon. The costs were expressed in 2016 Colombian pesos (1 USD = 3,051 Col$). Results In the vaginal delivery model, the average cost of care for a patient receiving prophylaxis with uterotonic agents was Col$ 347,750 with carbetocin and Col$ 262,491 with oxytocin,while theQALYs were 0.9980 and 0.9979, respectively. The incremental costeffectiveness ratio is above the cost-effectiveness threshold adopted by Colombia. In the model developed for cesarean section, the average cost of a patient receiving prophylaxis with uterotonics was Col$ 461,750 with carbetocin, and Col$ 481,866 with oxytocin, and the QALYs were 0.9959 and 0.9926, respectively. Carbetocin has lower cost and is more effective, with a saving of Col$ 94,887 per avoided hemorrhagic event. Conclusion In case of elective cesarean delivery, carbetocin is a dominant alternative in the prevention of PPH compared with oxytocin; however, it presents higher costs than oxytocin, with similar effectiveness, in cases of vaginal delivery.
first_indexed 2024-12-24T01:47:56Z
format Article
id doaj.art-b78939f6673344d0b554e1d95089dba0
institution Directory Open Access Journal
issn 0100-7203
language English
last_indexed 2024-12-24T01:47:56Z
publishDate 2018-05-01
publisher Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
record_format Article
series Revista Brasileira de Ginecologia e Obstetrícia
spelling doaj.art-b78939f6673344d0b554e1d95089dba02022-12-21T17:21:49ZengFederação Brasileira das Sociedades de Ginecologia e ObstetríciaRevista Brasileira de Ginecologia e Obstetrícia0100-72032018-05-0140524225010.1055/s-0038-1655747Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in ColombiaYaneth Gil-RojasPieralessandro LasalviaFabián HernándezCamilo Castañeda-CardonaDiego RosselliAbstract Objective To assess the cost-effectiveness of carbetocin versus oxytocin for prevention of postpartum hemorrhage (PPH) due to uterine atony after vaginal delivery/ cesarean section in women with risk factors for bleeding. Methods A decision treewas developed for vaginal delivery andanother one for cesarean, in which a sequential analysis of the results was obtained with the use of carbetocin and oxytocin for prevention of PPH and related consequences. A third-party payer perspective was used; only directmedical costs were considered. Incremental costs and effectiveness in terms of quality-adjusted life years (QALYs) were evaluated for a one-year timehorizon. The costs were expressed in 2016 Colombian pesos (1 USD = 3,051 Col$). Results In the vaginal delivery model, the average cost of care for a patient receiving prophylaxis with uterotonic agents was Col$ 347,750 with carbetocin and Col$ 262,491 with oxytocin,while theQALYs were 0.9980 and 0.9979, respectively. The incremental costeffectiveness ratio is above the cost-effectiveness threshold adopted by Colombia. In the model developed for cesarean section, the average cost of a patient receiving prophylaxis with uterotonics was Col$ 461,750 with carbetocin, and Col$ 481,866 with oxytocin, and the QALYs were 0.9959 and 0.9926, respectively. Carbetocin has lower cost and is more effective, with a saving of Col$ 94,887 per avoided hemorrhagic event. Conclusion In case of elective cesarean delivery, carbetocin is a dominant alternative in the prevention of PPH compared with oxytocin; however, it presents higher costs than oxytocin, with similar effectiveness, in cases of vaginal delivery.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032018000500242&tlng=encost-effectivenesscarbetocinoxytocinprevention postpartum hemorrhagepregnancyhigh-risk
spellingShingle Yaneth Gil-Rojas
Pieralessandro Lasalvia
Fabián Hernández
Camilo Castañeda-Cardona
Diego Rosselli
Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia
Revista Brasileira de Ginecologia e Obstetrícia
cost-effectiveness
carbetocin
oxytocin
prevention postpartum hemorrhage
pregnancy
high-risk
title Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia
title_full Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia
title_fullStr Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia
title_full_unstemmed Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia
title_short Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia
title_sort cost effectiveness of carbetocin versus oxytocin for prevention of postpartum hemorrhage resulting from uterine atony in women at high risk for bleeding in colombia
topic cost-effectiveness
carbetocin
oxytocin
prevention postpartum hemorrhage
pregnancy
high-risk
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032018000500242&tlng=en
work_keys_str_mv AT yanethgilrojas costeffectivenessofcarbetocinversusoxytocinforpreventionofpostpartumhemorrhageresultingfromuterineatonyinwomenathighriskforbleedingincolombia
AT pieralessandrolasalvia costeffectivenessofcarbetocinversusoxytocinforpreventionofpostpartumhemorrhageresultingfromuterineatonyinwomenathighriskforbleedingincolombia
AT fabianhernandez costeffectivenessofcarbetocinversusoxytocinforpreventionofpostpartumhemorrhageresultingfromuterineatonyinwomenathighriskforbleedingincolombia
AT camilocastanedacardona costeffectivenessofcarbetocinversusoxytocinforpreventionofpostpartumhemorrhageresultingfromuterineatonyinwomenathighriskforbleedingincolombia
AT diegorosselli costeffectivenessofcarbetocinversusoxytocinforpreventionofpostpartumhemorrhageresultingfromuterineatonyinwomenathighriskforbleedingincolombia